These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
947 related articles for article (PubMed ID: 29255992)
1. Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports? Svendsen K; Halvorsen KH; Vorren S; Samdal H; Garcia B Eur J Clin Pharmacol; 2018 Apr; 74(4):497-504. PubMed ID: 29255992 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758 [TBL] [Abstract][Full Text] [Related]
3. Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs. Dubrall D; Leitzen S; Toni I; Stingl J; Schulz M; Schmid M; Neubert A; Sachs B BMC Pharmacol Toxicol; 2021 Oct; 22(1):56. PubMed ID: 34620231 [TBL] [Abstract][Full Text] [Related]
4. Influence of age, sex and seriousness on reporting of adverse drug reactions in Sweden. Holm L; Ekman E; Jorsäter Blomgren K Pharmacoepidemiol Drug Saf; 2017 Mar; 26(3):335-343. PubMed ID: 28071845 [TBL] [Abstract][Full Text] [Related]
5. Systematic review of paediatric studies of adverse drug reactions from pharmacovigilance databases. Cliff-Eribo KO; Sammons H; Choonara I Expert Opin Drug Saf; 2016 Oct; 15(10):1321-8. PubMed ID: 27501085 [TBL] [Abstract][Full Text] [Related]
6. Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance. Blake KV; Zaccaria C; Domergue F; La Mache E; Saint-Raymond A; Hidalgo-Simon A Paediatr Drugs; 2014 Aug; 16(4):309-19. PubMed ID: 24898717 [TBL] [Abstract][Full Text] [Related]
7. The value of time-to-onset in statistical signal detection of adverse drug reactions: a comparison with disproportionality analysis in spontaneous reports from the Netherlands. Scholl JH; van Puijenbroek EP Pharmacoepidemiol Drug Saf; 2016 Dec; 25(12):1361-1367. PubMed ID: 27686554 [TBL] [Abstract][Full Text] [Related]
8. Adverse drug reactions in Colombian patients, 2007-2013: Analysis of population databases. Machado-Alba JE; Londoño-Builes MJ; Echeverri-Cataño LF; Ochoa-Orozco SA Biomedica; 2016 Mar; 36(1):59-66. PubMed ID: 27622439 [TBL] [Abstract][Full Text] [Related]
9. Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports. Leitzen S; Dubrall D; Toni I; Stingl J; Christ P; Köberle U; Schmid M; Neubert A; Sachs B Paediatr Drugs; 2023 Mar; 25(2):203-215. PubMed ID: 36369590 [TBL] [Abstract][Full Text] [Related]
10. Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™. Aagaard L; Strandell J; Melskens L; Petersen PS; Holme Hansen E Drug Saf; 2012 Dec; 35(12):1171-82. PubMed ID: 23072620 [TBL] [Abstract][Full Text] [Related]
11. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Tandon VR; Mahajan V; Khajuria V; Gillani Z Indian J Pharmacol; 2015; 47(1):65-71. PubMed ID: 25821314 [TBL] [Abstract][Full Text] [Related]
12. Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Tuccori M; Lapi F; Testi A; Coli D; Moretti U; Vannacci A; Motola D; Salvo F; Rivolta AL; Blandizzi C; Mugelli A; Del Tacca M Drug Saf; 2008; 31(12):1115-23. PubMed ID: 19026028 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy. Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462 [TBL] [Abstract][Full Text] [Related]
14. The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting. Karlsson SA; Jacobsson I; Boman MD; Hakkarainen KM; Lövborg H; Hägg S; Jönsson AK Eur J Clin Pharmacol; 2015 May; 71(5):631-6. PubMed ID: 25845655 [TBL] [Abstract][Full Text] [Related]
15. [Adverse drug reaction reports in Iceland from 2013 to 2016. A comparison with other Nordic countries]. Jonsdottir SS; Olafsdottir SM; Gudmundsdottir H Laeknabladid; 2017 Jul; 103(07-08):319-323. PubMed ID: 28816174 [TBL] [Abstract][Full Text] [Related]
16. Monitoring drug safety in Astrakhan, Russia. Kirilochev OO; Dorfman IP; Umerova AR Int J Risk Saf Med; 2015; 27 Suppl 1():S33-4. PubMed ID: 26639700 [TBL] [Abstract][Full Text] [Related]
18. Potentially inappropriate medications and adverse drug reactions in the elderly: a study in a PharmacoVigilance database. Montastruc F; Duguet C; Rousseau V; Bagheri H; Montastruc JL Eur J Clin Pharmacol; 2014 Sep; 70(9):1123-7. PubMed ID: 24925091 [TBL] [Abstract][Full Text] [Related]
19. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database. Castillon G; Salvo F; Moride Y Drug Saf; 2019 Jan; 42(1):27-34. PubMed ID: 30121742 [TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports. Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]